KURA
Price
$11.97
Change
+$0.84 (+7.55%)
Updated
Dec 3 closing price
Capitalization
1.04B
89 days until earnings call
Intraday BUY SELL Signals
MNPR
Price
$77.19
Change
+$1.24 (+1.63%)
Updated
Dec 3 closing price
Capitalization
512.69M
Intraday BUY SELL Signals
Interact to see
Advertisement

KURA vs MNPR

Header iconKURA vs MNPR Comparison
Open Charts KURA vs MNPRBanner chart's image
Kura Oncology
Price$11.97
Change+$0.84 (+7.55%)
Volume$1.45M
Capitalization1.04B
Monopar Therapeutics
Price$77.19
Change+$1.24 (+1.63%)
Volume$189.27K
Capitalization512.69M
KURA vs MNPR Comparison Chart in %
KURA
Daily Signal:
Gain/Loss:
MNPR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KURA vs. MNPR commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KURA is a Hold and MNPR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (KURA: $11.15 vs. MNPR: $75.86)
Brand notoriety: KURA and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KURA: 34% vs. MNPR: 91%
Market capitalization -- KURA: $1.04B vs. MNPR: $512.69M
KURA [@Biotechnology] is valued at $1.04B. MNPR’s [@Biotechnology] market capitalization is $512.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KURA’s FA Score shows that 1 FA rating(s) are green whileMNPR’s FA Score has 1 green FA rating(s).

  • KURA’s FA Score: 1 green, 4 red.
  • MNPR’s FA Score: 1 green, 4 red.
According to our system of comparison, MNPR is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KURA’s TA Score shows that 4 TA indicator(s) are bullish while MNPR’s TA Score has 4 bullish TA indicator(s).

  • KURA’s TA Score: 4 bullish, 3 bearish.
  • MNPR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KURA is a better buy in the short-term than MNPR.

Price Growth

KURA (@Biotechnology) experienced а -3.88% price change this week, while MNPR (@Biotechnology) price change was -14.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

KURA is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($1.04B) has a higher market cap than MNPR($513M). MNPR YTD gains are higher at: 244.818 vs. KURA (28.014). MNPR has higher annual earnings (EBITDA): -19.11M vs. KURA (-192.46M). KURA has more cash in the bank: 631M vs. MNPR (53.3M). MNPR has less debt than KURA: MNPR (80.4K) vs KURA (19.5M). KURA has higher revenues than MNPR: KURA (83.3M) vs MNPR (0).
KURAMNPRKURA / MNPR
Capitalization1.04B513M203%
EBITDA-192.46M-19.11M1,007%
Gain YTD28.014244.81811%
P/E RatioN/AN/A-
Revenue83.3M0-
Total Cash631M53.3M1,184%
Total Debt19.5M80.4K24,254%
FUNDAMENTALS RATINGS
KURA vs MNPR: Fundamental Ratings
KURA
MNPR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
10038
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3734
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MNPR's Valuation (30) in the null industry is in the same range as KURA (33) in the Biotechnology industry. This means that MNPR’s stock grew similarly to KURA’s over the last 12 months.

MNPR's Profit vs Risk Rating (38) in the null industry is somewhat better than the same rating for KURA (100) in the Biotechnology industry. This means that MNPR’s stock grew somewhat faster than KURA’s over the last 12 months.

MNPR's SMR Rating (97) in the null industry is in the same range as KURA (97) in the Biotechnology industry. This means that MNPR’s stock grew similarly to KURA’s over the last 12 months.

MNPR's Price Growth Rating (34) in the null industry is in the same range as KURA (37) in the Biotechnology industry. This means that MNPR’s stock grew similarly to KURA’s over the last 12 months.

MNPR's P/E Growth Rating (100) in the null industry is in the same range as KURA (100) in the Biotechnology industry. This means that MNPR’s stock grew similarly to KURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KURAMNPR
RSI
ODDS (%)
Bearish Trend 7 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
82%
Momentum
ODDS (%)
Bullish Trend 7 days ago
70%
Bearish Trend 7 days ago
85%
MACD
ODDS (%)
Bullish Trend 7 days ago
72%
Bullish Trend 7 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
72%
Bullish Trend 7 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
80%
Aroon
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
KURA
Daily Signal:
Gain/Loss:
MNPR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIFPX25.50N/A
N/A
Fidelity Advisor Founders M
FNDMX13.72N/A
N/A
Fidelity Series Sust Non-US Dev Mrkt Fd
HDVCX15.16N/A
N/A
Hartford International Equity C
MFRFX64.85N/A
N/A
MFS Research A
BINSX14.96N/A
N/A
Baillie Gifford International Alpha I

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with XNCR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-2.53%
XNCR - KURA
58%
Loosely correlated
-3.15%
CLDX - KURA
53%
Loosely correlated
+2.85%
RGNX - KURA
53%
Loosely correlated
-3.10%
IMTX - KURA
51%
Loosely correlated
-3.70%
DYN - KURA
48%
Loosely correlated
-2.96%
More

MNPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNPR has been loosely correlated with QNCX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MNPR jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-8.67%
QNCX - MNPR
35%
Loosely correlated
+6.94%
OCGN - MNPR
31%
Poorly correlated
-1.69%
IDYA - MNPR
31%
Poorly correlated
-1.75%
XNCR - MNPR
30%
Poorly correlated
-3.15%
KURA - MNPR
30%
Poorly correlated
-2.53%
More